What is neuroblastoma?

Neuroblastoma is a rare and aggressive childhood cancer that affects around 100 children each year in the UK. Most children are under the age of five.

Where in the body does neuroblastoma start?

Neuroblastoma is a cancer of the sympathetic nervous system, with tumours often occurring in the adrenal glands or abdomen.

Does neuroblastoma spread?

Half of all neuroblastoma cases are classified as ‘high-risk’, where the cancer has spread by the time it is diagnosed, and immediate treatment is required. Children diagnosed with high-risk neuroblastoma have about a 40-50% chance of long-term survival. It has one of the lowest survival rates of any childhood cancer and the causes are not known.

What treatment is there for neuroblastoma?

Due to the nature of neuroblastoma, treatment can be intensive and can include chemotherapy, surgery, radiotherapy, stem cell treatment and immunotherapy. Read more information on neuroblastoma treatment.

40-50% of children diagnosed with high-risk neuroblastoma will not respond completely (this is known as refractory) during standard treatment, or the cancer will come back (this is known as relapse) after. If a child does relapse with neuroblastoma, their chances of long-term survival are less than 10%.

MYCN

Another important factor is the presence of the MYCN oncogene, which is found in around 30% of patients and is strongly associated with a poor prognosis.

ALK - mutated ALK genes

Anaplastic Lymphoma Kinase (ALK) is a gene that tells your body how to make proteins that help cells talk to each other. Having mutated ALK genes is often indicative of a lower prognosis but the third-generation ALK inhibitor Lorlatinib trial is available for those deemed eligible.

Neuroblastoma progress

Despite progress in the treatment and understanding of neuroblastoma, survival rates – particularly when it comes to high-risk neuroblastoma – are still unacceptable.

It’s essential that promising developments in research are translated into effective treatment interventions that not only save lives but also offer the maximum quality of life after cancer. Solving Kids’ Cancer is working to initiate and fund innovative neuroblastoma research.

Latest

YSC Channel Swim for Joseph

The members of Ystradgynlais Swimming Club aged 6 - 15 plan to swim the length of the British channel (22 miles) between them in just 2 hours.
George's Story

Around 100 children are diagnosed with neuroblastoma every year in the UK, with nearly half categorised as 'high-risk', a diagnosis that's even more challenging to treat. George was diagnosed with high-risk neuroblastoma at 17 years old in January 2020. He is currently enrolled on the Lorlatinib trial which is showing positive results so far.
70 miles in 7 days

Being a mam myself Joseph’s story has touched my heart.
Mikey's Story

Around 100 children are diagnosed with neuroblastoma every year in the UK, with nearly half categorised as 'high-risk', a diagnosis that's even more challenging to treat. Mikey was diagnosed at just 20 months old, now 5 years old he has completed the Bivalent vaccine trial and started year 1 at school.

Chloe’s Journey

Chloe was diagnosed with high-risk neuroblastoma at just 2 years old. Chloe is now 10 years old and in February 2020 her parents were given the devastating news that she had relapsed for the second time with her disease progressing in February 2021.
Joseph's Campaign

Joseph was diagnosed with high-risk neuroblastoma in April 2021 at just three years old. His family are fundraising for further treatment, either to get their son into remission or to try and keep the cancer away if his frontline treatment does go to plan. This could cost hundreds of thousands of pounds.
Flora's Campaign

In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma.
Peter's Campaign

11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. His family are fundraising for further treatment either to get Peter back into remission or to try and keep the cancer away if his treatment goes to plan. This could cost hundreds of thousands of pounds.
Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.
Ollie’s Appeal

Ollie's family shared the devastating news that their beautiful boy passed away on Sunday 18th July 2021.
Henry's Urgent Appeal

Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family are appealing for your help to raise £163,000 by January 2021.
Nellie-Rose's Campaign

Nellie-Rose is battling a disease no child should have to. She has high-risk neuroblastoma that has a 40-50% chance of long-term survival at diagnosis.
Poppy's Campaign

Poppy was diagnosed with high-risk neuroblastoma at just four years old. Her family are fundraising for further treatment, either to get their daughter into remission or to try and keep the cancer away if her frontline treatment does go to plan.
What is neuroblastoma?

Neuroblastoma is a rare and aggressive childhood cancer that affects around 100 children each year in the UK. It has one of the lowest survival rates.